Clinical Research Directory
Browse clinical research sites, groups, and studies.
SBRT for Oligometastatic Lymph Node Recurrence in Prostate Cancer: a Single Institution Experience
Sponsor: Kantonsspital Graubünden
Summary
Single-institution retrospective analysis for predictive factors of prostate cancer patients presenting with isolated or limited lymph node (LN) recurrence (1-3 lesions) on F-Ccholine PET-CT (CholPET) treated with SBRT between January 2010 and July 2015.
Official title: Predictive Factors for the Benefit of Stereotactic Body Radiotherapy for Oligometastatic Lymph Node Recurrence in Prostate Cancer: a Single Institution Experience
Key Details
Gender
MALE
Age Range
18 Years - 85 Years
Study Type
OBSERVATIONAL
Enrollment
25
Start Date
2010-01
Completion Date
2018-07
Last Updated
2026-11-20
Healthy Volunteers
Not specified
Interventions
Cyberknife Radiation Therapy
Stereotactic Radiotherapy of lymphnode recurrence after prostatectomy +/- salvage radiotherapy
Locations (1)
Juergen Curschmann
Zurich, Switzerland